Prospective, Randomized, Single-Center Evaluation of the Cypher (TM) Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions

Trial Profile

Prospective, Randomized, Single-Center Evaluation of the Cypher (TM) Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms BBK
  • Most Recent Events

    • 01 Dec 2008 Results have been reported in the European Heart Journal 29: 2859-2867, No. 23, Dec 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top